retatrutide 10mg peptide (RUO) | ≥99% Purity | Research Grade | 10mg Reta GLP-3R (Retatrutide) 10mg |

The information below describes the dosing approach used in the Phase 2 clinical trial (Jastreboff et al., NEJM 2023) for context only

The compounded GLP-1 medications it connects patients with - semaglutide starting at $199/month and tirzepatide starting at $349/month - are priced well below FDA-approved branded alternatives, with the tradeoffs that compounded medications carry: no FDA premarket review as finished products, and an active regulatory environment that could change their availability

In lower-income states like Mississippi, Louisiana, and West Virginia, not so much but it depends on the price tag people are willing to put on feeling or looking healthier

Pricing clarity: Is the billing cadence clear

Avoid injecting directly around the navel area, as this is more sensitive

These developments will have implications for numerous stakeholders within the industry